CClinicalTrials.gg
CompletedNCT01570114Updated Apr 4, 2012

Covered Metallic Stent and Benign Colonic Strictures

An observational study in Colonic Diseases, Stricture and Occlusion, sponsored by Société Française d'Endoscopie Digestive. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-04-04.

Sponsored by Société Française d'Endoscopie Digestive · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
43
Ages
18 Years and older
Sex
All
01

Study summary

Self-expanding metallic stent placement is a safe and effective endoscopic procedure increasingly used to relieve colonic obstruction. Fully covered metal stents (FCSEMS) and plastic stents have been recently developed to reduce both hyperplastic (non tumoral) and tumoral tissue ingrowth. These fully covered metal or plastic stents have several advantages over non-covered stents, including the possibility of retrieval and limited local tissue reaction, while providing alleviation of obstruction at possibly lower costs. Only few reports of fully covered metal stent placement in patients with benign colorectal strictures are available in the literature. The aim of this study was to assess the effectiveness of FCSEMS in the management of the colonic benign strictures.

Read the detailed description

It is a national multicentric retrospective study on the use of fully covered metal stent placement in patients with benign colorectal strictures.

Consecutive patients above 18 years of age with a symptomatic benign colonic stricture despite optimal medical and/or endoscopic dilation therapy and which required the use of a FCSEMS were included. All strictures were confirmed to be benign by histology. All details concerning previous history, origins and treatment (medical or endoscopic) of the colonic stenosis were collected from the medical file.

Senior endoscopists with an experience of more than 50 colonic stent placements performed the procedure under general propofol-induced anesthesia with the same technic (The stent was placed under fluoroscopic and videoendoscopic controls).

Patients were required after the procedure to take oral osmotic laxatives regularly. Post-stenting complications were defined as immediate (during the procedure), early (occurring ≤ 30 days) and late (> 30 days) after the procedure. Stent removal and routine follow up endoscopy were scheduled 4 to 6 weeks after placement in most patients or earlier if complications occurred.

All patients were followed up at regular intervals based on their clinical situation. A retrospective chart review was performed to analyze the long-term outcome of the patients.

02

Conditions studied

  • Colonic Diseases
  • Stricture
  • Occlusion

Keywords

  • Covered metallic stent
  • colon
  • benign stricture
03

In context

Colonic Diseases

142 studies on the registry are indexed under Colonic Diseases; 22 are open to participants now.

This study's enrollment of 43 is below the median of 170 across 48 observational studies indexed under Colonic Diseases.

Browse Colonic Diseases studies →

Lead sponsor

Société Française d'Endoscopie Digestive is the lead sponsor of 25 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in universitary tertiary care center benefited from a fully covered metallic colonic stent for treatment of benign stricture

Inclusion criteria

  • patients above 18 years of age
  • symptomatic benign colonic stricture despite optimal medical and/or endoscopic dilation therapy

Exclusion criteria

Exclusion Criteria:

  • Previous insertion or treatment of the stricture with metallic (covered or uncovered) stent
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
43 participants (actual)

Groups and cohorts

  • covered metallic stent

    Endoscopically insertion of fully covered metallic stent on benign colonic strictures

    Device: Fully covered metallic colonic stent

Interventions

  • DeviceFully covered metallic colonic stent

    Endoscopically insertion of fully covered metallic colonic stent

06

What researchers measure

Primary outcomes

  1. Symptom resolution of colonic occlusion

    Defined as the clinical (stools, stop pain) and radiological evidence of colonic decompression within 48 hours of stent insertion and without the need for reintervention

    Time frame: 48 hours

Secondary outcomes

  1. Successful stent placement

    On the first attempt with complete deployment and precise positioning of the stent at the location of the stenosis, which was confirmed by fluoroscopy

    Time frame: Immediatly after stent insertion (one minute)

  2. Successful stent retrieval

    Possibility of retrieval the stent with a snare or a forceps

    Time frame: One minute (during colonoscopy for stent retrieval)

  3. Occurrence of any complication during interventional endoscopy, stent retrieval and the follow-up

    Perforation, bleeding, migration, pain, fecal incontinence and foreign body sensation, stent impaction and hyperplastic tissue overgrowth

    Time frame: 60 days

  4. Recurrence of colonic occlusion

    New episode of occlusion or subocclusion (pain with stool and gas discontinuation and imaging with cecum dilation) after stent retrieval or migration

    Time frame: 60 days, 6 months and one year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01570114
Lead sponsor
Société Française d'Endoscopie Digestive
Responsible party
VANBIERVLIET (Medical doctor - study coordinator and director of the endoscopy unit in universitary hospital of Nice (France), Société Française d'Endoscopie Digestive) — Principal investigator
First posted
Apr 4, 2012
Start date
Jan 2011
Primary completion
Sep 2011
Completion
Oct 2011
Last update
Apr 4, 2012

Study contacts

Geoffroy Vanbiervliet, MD
principal investigator · Société Française d'Endoscopie Digestive

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion